NO831562L - Analogifremgangsmaate for fremstilling av fysiologisk aktive kinolinderivater - Google Patents

Analogifremgangsmaate for fremstilling av fysiologisk aktive kinolinderivater

Info

Publication number
NO831562L
NO831562L NO831562A NO831562A NO831562L NO 831562 L NO831562 L NO 831562L NO 831562 A NO831562 A NO 831562A NO 831562 A NO831562 A NO 831562A NO 831562 L NO831562 L NO 831562L
Authority
NO
Norway
Prior art keywords
radical
acid
alkyl
methyl
compounds
Prior art date
Application number
NO831562A
Other languages
English (en)
Norwegian (no)
Inventor
David James Le Count
Robert James Pearce
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838302236A external-priority patent/GB8302236D0/en
Application filed by Ici Plc filed Critical Ici Plc
Publication of NO831562L publication Critical patent/NO831562L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO831562A 1982-05-04 1983-05-03 Analogifremgangsmaate for fremstilling av fysiologisk aktive kinolinderivater NO831562L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8212787 1982-05-04
GB838302236A GB8302236D0 (en) 1983-01-27 1983-01-27 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
NO831562L true NO831562L (no) 1983-11-07

Family

ID=26282723

Family Applications (1)

Application Number Title Priority Date Filing Date
NO831562A NO831562L (no) 1982-05-04 1983-05-03 Analogifremgangsmaate for fremstilling av fysiologisk aktive kinolinderivater

Country Status (13)

Country Link
US (1) US4607039A (en22)
EP (1) EP0093521B1 (en22)
KR (1) KR840004726A (en22)
DD (1) DD209817A5 (en22)
DE (1) DE3377796D1 (en22)
DK (1) DK199183A (en22)
ES (1) ES8502093A1 (en22)
FI (1) FI831537A7 (en22)
GB (1) GB8310261D0 (en22)
GR (1) GR78484B (en22)
IL (1) IL68513A0 (en22)
NO (1) NO831562L (en22)
PT (1) PT76630B (en22)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308601D0 (en) * 1983-03-29 1983-05-05 Ici Plc Heterocyclic compounds
JPH064584B2 (ja) * 1984-02-29 1994-01-19 沢井製薬株式会社 新規アニリド誘導体
US5179107A (en) * 1990-09-07 1993-01-12 Schering Corporation Antiviral quinolinone compounds
US5190956A (en) * 1990-09-07 1993-03-02 Schering Corporation Certain N-substituted 3-oximino-2,4-dioxoquinolin-2,4-(1H)diones useful for treating viral infections
EP0549729B1 (en) * 1990-09-07 1997-12-17 Schering Corporation Antiviral compounds and antihypertensive compounds
GB9022785D0 (en) * 1990-10-19 1990-12-05 Merck Sharp & Dohme Therapeutic agents
US5179093A (en) * 1991-05-10 1993-01-12 Schering Corporation Quinoline-diones
FR2795645B1 (fr) * 1999-06-30 2001-09-21 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
US6566361B2 (en) 1999-06-30 2003-05-20 Laboratories, Upsa Azapirone pain treatment
MY120631A (en) * 2000-09-08 2005-11-30 Union Pharma Scient Appl Novel pharmaceutical combination having analgesic activity
WO2007089634A2 (en) * 2006-01-30 2007-08-09 Merck & Co., Inc. Inhibitors of fatty acid synthase (fas)
US8680116B2 (en) * 2009-07-22 2014-03-25 Merck Sharp & Dohme Corp. Quinolinone PDE2 inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US16394A (en) * 1857-01-13 Improvement in gotton-gins
DE430960C (de) * 1924-07-11 1926-06-23 J G Farbenindustrie Akt Ges Verfahren zur Darstellung von basischen AEthern von Chinolinderivaten
US1572768A (en) * 1925-06-26 1926-02-09 Winthrop Chem Co Inc Pharmaceutical product
US1860286A (en) * 1929-05-16 1932-05-24 Soc Of Chemical Ind Basic ethers of aryl-quinolines
GB349761A (en) * 1929-05-16 1931-06-04 Chem Ind Basel Manufacture of aminoalkoxy-derivatives of aryl-quinolines
US4035374A (en) * 1973-05-03 1977-07-12 Smith Kline & French Laboratories Limited Imidazolyl alkylaminopyridone and pyridinethione compounds
US4260764A (en) * 1976-12-22 1981-04-07 Pfizer Inc. 9-Hydroxyoctahydrobenzo [C] quinolines and intermediates therefor
US4343805A (en) * 1978-12-16 1982-08-10 John Wyeth & Brother Limited Heterocyclic compounds
US4235909A (en) * 1979-04-19 1980-11-25 Eli Lilly And Company Octahydro-2H-pyrrolo[3,4-g]quinolines
GR73576B (en22) * 1980-03-01 1984-03-20 Wyeth John & Brother Ltd
IN158970B (en22) * 1981-06-09 1987-02-28 Ici Plc

Also Published As

Publication number Publication date
KR840004726A (ko) 1984-10-24
ES522089A0 (es) 1984-12-16
PT76630B (en) 1985-12-03
FI831537L (fi) 1983-11-05
DE3377796D1 (en) 1988-09-29
PT76630A (en) 1983-06-01
GR78484B (en22) 1984-09-27
DK199183A (da) 1983-11-05
EP0093521A3 (en) 1984-08-01
FI831537A0 (fi) 1983-05-04
US4607039A (en) 1986-08-19
IL68513A0 (en) 1983-07-31
FI831537A7 (fi) 1983-11-05
DD209817A5 (de) 1984-05-23
EP0093521B1 (en) 1988-08-24
GB8310261D0 (en) 1983-05-18
DK199183D0 (da) 1983-05-04
EP0093521A2 (en) 1983-11-09
ES8502093A1 (es) 1984-12-16

Similar Documents

Publication Publication Date Title
SU1644716A3 (ru) Способ получени пиперазинилгетероциклических соединений или их фармацевтически приемлемых кислотно-аддитивных солей
NO831562L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive kinolinderivater
US6391891B1 (en) Bicyclic compounds as ligands for 5-HT1 receptors
JP2000511534A (ja) ベンゾオキサジノンドーパミンd4受容体アンタゴニスト
EP0066993B1 (en) Quinoline derivatives
NO146359B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater
JP3057095B2 (ja) イサチン誘導体、その製造方法及びその使用方法
US4565816A (en) Piperazine derivatives and pharmaceutical composition containing them
RU2314305C2 (ru) Производные 4-(тио- или селеноксантен-9-илиден)-пиперидина или акридина, фармацевтическая композиция на их основе и применение
IE45051B1 (en) 2-substituted-4-amino-6,7-dimethoxy-quinazolines
NO327549B1 (no) Benzo[G]kinolinderivater for behandling av glaukom og myopi
CA1254561A (en) 3-aminocarbonylmethoxy-5-phenylpyrazole compounds, method of their preparation and pharmaceutical compositions containing these compounds
US4607040A (en) Quinoline derivatives which are 5-hydroxytryptamine antagonists
US3888983A (en) Derivatives of thiazolino-pyrimidin-6-ones, in inducing analgesia
CA2317515A1 (en) Oxazole derivatives as serotonin-1a receptor agonists
NO155056B (no) Sprengstoff.
US4420476A (en) Benzofuro[3,2-c]pyrazol-3-amine derivatives
US4576953A (en) Quinoline derivatives
DK169948B1 (da) Mellemprodukter til brug ved fremstilling af pyrimido[4,5-g]quinolin-derivater eller salte deraf
EP0268396B1 (en) 4-(benzoyl)thiophene(or furan)-sulfonamide and derivatives thereof for the topical treatment of elevated intraocular pressures
US4994448A (en) Condensed quinolinium and isoquinolinium derivatives
DK157683B (da) Analogifremgangsmaade til fremstilling af et benzoquinolizinderivat eller et farmaceutisk acceptabelt syreadditionssalt deraf
DK150158B (da) Analogifremgangsmaade til fremstilling af 4-phenylthieno-(2,3-c)piperidiner eller fysiologisk acceptable syreadditionssalte deraf
US3239514A (en) Phenothiazine derivatives substituted by a monovalent sulfur function in 3-position
CA1077040A (en) Pharmaceutically active decahydroquinoline derivatives